Pfizer to pay $55 million in drug misbranding case - Article Photos 1/1

FILE- In this Thursday, July 12, 2012, file photo, Centrum multivitamins are shown on the packaging line at the Pfizer plant in Montreal. The Justice Department said Wednesday, Dec. 12, 2012, that Pfizer Inc. will pay $55 million to resolve allegations that Wyeth LLC promoted the drug Protonix for uses that were not approved by the Food and Drug Administration. Pfizer acquired Wyeth in October 2009. (AP Photo/The Canadian Press, Graham Hughes, File)